NCT00946777
Completed
Not Applicable
Barrier Function Measurement in Dry Eye Patients After Using Systane Ultra for 30 Days
ConditionsDry Eye
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Dry Eye
- Sponsor
- Alcon Research
- Enrollment
- 19
- Primary Endpoint
- Percent change from baseline of corneal fluorescein
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The primary objective is to determine if there is a correlation between reductions in corneal staining and improvements in corneal barrier function.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients must have moderate corneal staining and exhibit a need to use artificial tears.
Exclusion Criteria
- •Patients can not participate in any other ophthalmic drug or device clinical trial within 30 days of the baseline visit.
Outcomes
Primary Outcomes
Percent change from baseline of corneal fluorescein
Time Frame: 30 days
Secondary Outcomes
- Adverse event occurence(30 Days)
Similar Trials
Completed
Phase 1
IVIG-eye Drops Treatment for Dry Eye DiseaseDry EyeNCT03992482Sandeep Jain, MD27
Completed
Not Applicable
Staining in a Healthy, Non-Dry Eye PopulationNormal Healthy EyesNCT00643942Alcon Research120
Unknown
Not Applicable
Corneal Thickness Changes in Patient Undergoing Dry Eye ManagmentDry Eye DiseaseNCT04970329University of Faisalabad96
Terminated
Phase 1
Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD)Dry EyeOcular Graft vs Host DiseaseMeibomian Gland DysfunctionNCT02975557Sandeep Jain, MD15
Recruiting
Not Applicable
The influence of corneal epithelium barrier function caused by wearing tinted contact lensesJPRN-UMIN000033147St.Marianna University School of Medicine20